Effect of wet cupping) in knee osteoarthritis

Efficacy of Hijamah-bis-shurt(wet cupping) in knee osteoarthritis.A randomized comparative clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053960

Enrollment

Registered

2023-06-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Hijamah-bis-shurt(wet cupping): Hijamah-bis-shurt(wet cupping) 6 sittings at every week for 6 weeks Intervention2: Hijamah-bis-shurt(wet cupping: Hijamah-bis-shurt(wet cupping 6 sitting

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex in the age group of 30 to 65 years. 2. Patients with knee OA of Kellgren-Lawrence grade I-III 3. Patients having Tahajjur al-Maf ?sil (Osteoarthritis) of knee(s) fulfilling the following American College of Rheumatology (ACR) criteria: a. Wajaâ?? al-Rukba (Knee Pain) (Khayat, 1983) b. Osteophytes (on radiographs) and at least 1 of the following 3 criteria: i. Age â?¥ 50 years ii. Tayabbus al-Mafsil (Joint Stiffness) â?¤ 30 minutes (Khayat, 1983) iii. Farqaâ?? Mafsiliyya (Joint Crepitus) (Khayat, 1983

Exclusion criteria

Exclusion criteria: 1.Patients with Knee OA of Kellgren-Lawrence grade IV 2.Accompanying OA of Hip. 3.Secondary OA, RA, systemic joint disease, or any other type of arthritis. 4.Arthroscopy or any knee surgery in the previous 6 months 5.Intra-articular treatment (e.g., corticosteroids or hyaluronic acid) or treatment with medicine for OA in the previous 3 months (e.g. glucosamine sulphate, chondroitin sulphate, diacerein, piascledine). 6.Patients of bleeding disorders. 7.Patients with anemia and diabetes mellitus. 8.ESR > 40 mm/h and CRP level >10 mg/L 9.Any significant systemic diseases (cardiovascular, gastrointestinal, hepatic, renal, neurologic or psychiatric disorder) that may lead to difficulty complying with the protocol. 10.Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
The efficacy of wet cupping therapy will be assessed on the basis of reduction in knee pain and stiffness and improvement in limitation of physical function by using WOMAC score, and VAS will also be used for assessing reduction in knee pain.Timepoint: baseline,2 weeks,4 weeks,8 weeks	—

Secondary

Measure	Time frame
IMPROVEMENT IN QOLTimepoint: 6WEEKS	—

Countries

India

Contacts

Public ContactDr HUMMA

Regional research institute of unani medicine Srinagar/CCRUM

humaccrum@gmail.com9796550059

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026